In his complaint, Michael Wade Nance said his veins were so severely compromised that they were likely to blow and cause him ...

As NAD+ injections and IV drips trend from TikTok to the Kardashians, the science of longevity remains a work in progress. Explore the benefits, side effects, and the debate between oral precursors ...

SAN FRANCISCO, March 09, 2026 (GLOBE NEWSWIRE) -- Hydration Room, a leading provider of medically supervised IV and injection therapy, today announced the opening of its newest Northern California ...

Add Yahoo as a preferred source to see more of our stories on Google. New particle technology packs antibodies into small injections that may replace long intravenous infusions. (CREDIT: Shutterstock) ...

Skyrizi is used to treat autoimmune and inflammatory conditions like Crohn’s disease and plaque psoriasis. It is administered via intravenous injection by a healthcare professional or subcutaneous ...

IV therapy is gaining popularity as a new approach to wellness, delivering a personalized vitamin cocktail directly into the bloodstream. Nationwide, the industry has experienced significant growth, ...

Four patients with infantile-onset Pompe’s disease received a single intravenous injection of an adeno-associated virus serotype 9 vector carrying codon-optimized complementary DNA encoding human acid ...

Samples of heart tissue from the study. The sample on the right, which was treated with the PLP therapy, shows decreased scarring (in blue) compared to the untreated sample on the left. Scientists at ...

Scientists have developed a lipid nanoparticle system capable of delivering messenger RNA (mRNA) to the brain via intravenous injection, a challenge that has long been limited by the protective nature ...

Idelvion (coagulation factor IX [recombinant], albumin fusion protein) is a prescription drug used to treat and help prevent bleeding episodes in people with hemophilia B. Idelvion is given as an ...

Dr. Eric K. Singhi discusses the benefit of subcutaneous immunotherapy following the FDA approval of subcutaneous Opdivo for patients with solid tumors. On Dec. 27, 2024, the Food and Drug ...